相关实验视频

Updated: Jan 7, 2026

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

跨导管大动脉置换 (TAVR) 后的准膜泄漏:文学综述

Giorgio Sciaramenti¹, Edoardo Menzato¹, Stefano Clo'¹

¹Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Journal of clinical medicine

|December 30, 2025

概括

准膜泄漏 (PVLs) 是通过导管的大动脉置换 (TAVR) 后的一种并发症. 本综述总结了TAVR患者的PVL发病率,预测因素,诊断和管理策略.

科学领域:

心血管医学心血管医学
干预心脏病学干预心脏病学

背景情况:

严重的大动脉狭窄症对健康构成重大风险,特别是在症状明显的个体中.
过导管大动脉置换 (TAVR) 为手术大动脉置换 (SAVR) 提供了一种不那么侵入性的替代方案,改善了患者的治疗结果.
副漏 (PVLs) 是TAVR后的一个关键并发症,与增加的死亡率和心力衰竭住院病例有关.

研究的目的:

系统地审查发生率,预测因子,诊断方法和对TAVR后膜漏洞 (PVLs) 的管理策略.
为了巩固目前关于PVL并发症的知识,在通过导管更换大动脉之后.
为临床实践提供有关TAVR后PVL识别和治疗的信息.

主要方法:

在TAVR后报告PVL的研究的系统文献综述.
对PVL的诊断技术和管理方法的分析.
评估患者数据以确定PVL发展的预测因素.

主要成果:

PVL与不良结果有关,包括增加死亡率和心力衰竭住院治疗.
术前规划可以识别患有PVL风险较高的患者.
虽然新的门已经减少了PVL的发病率,但并发症仍然很重要,需要多式诊断方法.

结论:

对于PVL的管理策略,从保守的方法到针对特定病例的皮关闭或TAVR中的TAVR等干预措施.
准确的PVL评估需要多式诊断方法,因为复杂的大动脉解剖学.
需要进一步的研究来完善在TAVR之后PVL的管理策略.

关键词:

在TAVRR中,我们可以看到.一大动脉的反.一个漏洞的漏洞.抛膜体泄漏抛膜体泄漏

更多相关视频

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

相关概念视频

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...

Aortic Regurgitation I: Introduction

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Mitral Regurgitation I: Introduction

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...